Therefore, Tyrobp deletion improves the behavior of APP/PSEN1, MAPTP301S and Q175 mice, in each case, decreasing many of the same genes even if they are not pathologically increased in the presence of Tyropb. Our focus was on the striatum, an area not assayed in the AD studies. This evidence concerns the gene APP and Alzheimer disease.